Study: Engineered Immune Cells and Targeted Treatments May Slow the Spread of Triple-Negative Breast Cancer
- March 16, 2026
Breakthrough DNA Repair Inhibitor Advances Rapidly Toward Clinic: Artios’ ART6043 Earns FDA Fast Track Status for Resistant Breast Cancer
Bristol Myers Squibb Reports Positive Phase 3 Data for Mezigdomide-Based Oral Regimen in Relapsed or Refractory Multiple Myeloma
FDA Explains Rejection of Regenxbio’s Hunter Syndrome Gene Therapy
LISTEN TO OUR PODCAST
THE LATEST FROM PATIENT WORTHY
FEATURED
UPCOMING EVENTS
SIGN UP FOR OUR NEWSLETTER
Study: Engineered Immune Cells and Targeted Treatments May Slow the Spread of Triple-Negative Breast Cancer bit.ly/40q55X8 Read now at PatientWorthy.com
#PatientWorthy #breastcancer #Triple-NegativeBreastCancer
Breakthrough DNA Repair Inhibitor Advances Rapidly Toward Clinic: Artios' ART6043 Earns FDA Fast Track Status for Resistant Breast Cancer bit.ly/4btK5UC Read now at PatientWorthy.com
#PatientWorthy #breastcancer #ArtiosPharma #art6043 #fdafasttrackstatus
This image represents Stiff Person Syndrome. A rare and often invisible neurological disease that locks the body without warning. The rigid lines show muscles that will not relax. The frozen movement shows how everyday moments can suddenly stop. What looks calm on the outside often hides fear pain and exhaustion. People with Stiff Person Syndrome live with constant uncertainty. A sound stress or gentle touch can trigger painful spasms. Many are misunderstood because you cannot always see what is happening. Awareness matters. It leads to earlier diagnosis, better care and more research. It reminds those living with this disease that they are not alone. Please take a moment to learn share and listen. Visibility can change lives. 💙 #stiffpersonsyndrome #raredisease #invisibleillness #chronicillnessawareness #PatientWorthy#SeeTheInvisible #spsawareness
